Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Multicentre Observational Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Real Life in Patients With Rheumatoid Arthritis

NCT02094326 is registered in ClinicalTrials.gov with Fundación Andaluza de Reumatología as lead sponsor.

NCT NCT02094326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02094326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Multicentre Observational Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Real Life in Patients With Rheumatoid Arthritis
Lead sponsor
Fundación Andaluza de Reumatología
Phase
Observational
Overall status
Completed
Start date
March 31, 2014
Completion date
October 31, 2014
Enrollment
301 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis